RESUMEN
COG1410, a small, novel ApoE-mimetic peptide derived from the receptor binding region of apolipoprotein E (ApoE), has been classified as anti-inflammatory in nature and improves motor, sensorimotor, and cognitive dysfunction following cortical contusion injury (CCI). In order to further examine COG1410's preclinical efficacy on cognitive recovery, the present study evaluated COG1410 following moderate fluid percussion injury (FPI). Animals were prepared with a moderate, unilateral FPI over the hippocampus. Following FPI, animals received a regimen of five doses of COG1410 or vehicle at 2 and 4h (1.0mg/kg, i.v.) followed by additional doses administered 24, 48, and 72 h (1.0mg/kg, i.p.). Prior to injury, animals were trained for 4 days (4 trials/day) in the Morris water maze (MWM) and then tested for retrograde amnesia on post-FPI day 11 and then on a working memory task on day 18. Testing for motor dysfunction on the tapered balanced beam began on day 2 post-FPI. Administration of this regimen of COG1410 significantly improved retention of memory in the retrograde amnesia test compared to vehicle post-FPI. However, COG1410 did not significantly improve acquisition of working memory in the MWM. Motor dysfunction on the tapered beam post-FPI was improved in the COG1410-treated group compared to vehicle treatment. Cortical lesion analysis revealed that the COG1410-treated animals demonstrated significantly less tissue loss compared to vehicle-treated animals. The results of this study suggest that COG1410 significantly limited the behavioral dysfunction and tissue loss associated with FPI and demonstrated continued preclinical efficacy for TBI.
Asunto(s)
Apolipoproteínas E/administración & dosificación , Lesiones Encefálicas/tratamiento farmacológico , Corteza Cerebral/patología , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Recuperación de la Función/efectos de los fármacos , Animales , Apolipoproteínas E/síntesis química , Lesiones Encefálicas/complicaciones , Lesiones Encefálicas/patología , Trastornos del Conocimiento/complicaciones , Trastornos del Conocimiento/patología , Modelos Animales de Enfermedad , Esquema de Medicación , Hipocampo/lesiones , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Masculino , Trastornos de la Memoria/complicaciones , Ratas , Ratas Long-EvansRESUMEN
Hypertonic saline (HTS) is an accepted treatment for traumatic brain injury (TBI). However, the behavioral and cognitive consequences following HTS administration have not thoroughly been examined. Recent preclinical evidence has suggested that nicotinamide (NAM) is beneficial for recovery of function following TBI. The current study compared the behavioral and cognitive consequences of HTS and NAM as competitive therapeutic agents for the treatment of TBI. Following controlled cortical impact (CCI), bolus administrations of NAM (500 mg/kg), 7.5% HTS, or 0.9% saline Vehicle (1.0 mL/kg) were given at 2, 24, and 48 h post-CCI. Behavioral results revealed that animals treated with NAM and HTS showed significant improvements in beam walk and locomotor placing compared to the Vehicle group. The Morris water maze (MWM) retrograde amnesia test was conducted on day 12 post-CCI and showed that all groups had significant retention of memory compared to injured, Vehicle-treated animals. Working memory was also assessed on days 8-20 using the MWM. The NAM and Vehicle groups quickly acquired the task; however, HTS animals showed no acquisition of this task. Histological examinations revealed that the HTS-treated animals lost significantly more cortical tissue than either the NAM or Vehicle-treated animals. HTS-treated animals showed a greater loss of hippocampal tissue compared to the other groups. In general, NAM showed a faster rate of recovery than HTS without this associated tissue loss. The results of this study reiterate the strengths of NAM following injury and show concerns with bolus administrations of HTS due to the differential effects on cognitive performance and apparent tissue loss.
Asunto(s)
Lesiones Encefálicas/tratamiento farmacológico , Fármacos del Sistema Nervioso Central/farmacología , Cognición/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Niacinamida/farmacología , Solución Salina Hipertónica/farmacología , Animales , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/patología , Lesiones Encefálicas/patología , Locomoción/efectos de los fármacos , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Memoria a Corto Plazo/efectos de los fármacos , Pruebas Neuropsicológicas , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Resultado del TratamientoRESUMEN
The selected strain of rodent used in experimental models of traumatic brain injury is typically dependent upon the experimental questions asked and the familiarity of the investigator with a specific rodent strain. This archival study compares the injury responsiveness and recovery profiles of two popular outbred strains, the Long-Evans (LE) and the Sprague-Dawley (SD), after brain injury induced by lateral fluid percussion injury (LFPI). General findings include a significantly longer duration of unconsciousness in LE rats, but similar durations of apnea. Both strains displayed the same level of initial FPI-induced behavioral deficits, followed by a more rapid rate of functional recovery in SD rats. Cortical volume loss was not significantly different, but close inspection of the data suggests the possibility that LE rats may be more susceptible to damage in the hemisphere contralateral to the injury site than are SD rats. It is hoped that the information provided here encourages greater attention to the subtle differences and similarities between strains in future pre-clinical efficacy studies of traumatic brain injury.
Asunto(s)
Lesiones Encefálicas/patología , Lesiones Encefálicas/fisiopatología , Encéfalo/patología , Encéfalo/fisiopatología , Animales , Animales no Consanguíneos/fisiología , Apnea/etiología , Conducta Animal/fisiología , Lesiones Encefálicas/complicaciones , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Modelos Animales de Enfermedad , Lateralidad Funcional/fisiología , Masculino , Degeneración Nerviosa/etiología , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Regeneración Nerviosa/fisiología , Ratas , Ratas Long-Evans , Ratas Sprague-Dawley , Recuperación de la Función/fisiología , Especificidad de la Especie , Inconsciencia/etiologíaRESUMEN
Indices of discrimination between words of different syntactic classes were examined in a group of 22 preschool-age children utilizing event-related potential (ERP) procedures. Video taped scenes depicted an actor performing actions with a set of toys. ERPs were recorded to spoken nouns or verbs that either matched or failed to match the action name or object name in the video scene. ERPs were analyzed using peak amplitude-ANOVA procedures and principal components analysis-ANOVA. Results indicated good convergence across analysis approaches. More specifically, P100 and N220 varied bilaterally over frontal electrode sites and discriminated between different syntactic classes for both match and mismatch situations. Based on comparisons with adult data from previous work [Molfese, D.L., Burger-Judisch, L., Gill, L.A., Golinkoff, R.M., Hirsh-Pasek, K., 1996. Electrophysiological correlates of noun-verb processing in adults. Brain and Language 54 388-413], it is suggested that the pattern of brain involvement underlying syntactic class discriminations undergo developmental changes between the preschool years and adulthood.
Asunto(s)
Potenciales Evocados/fisiología , Lenguaje , Estimulación Acústica , Preescolar , Electroencefalografía , Femenino , Lateralidad Funcional/fisiología , Humanos , Masculino , Estimulación Luminosa , Análisis de Componente Principal , Psicolingüística , Percepción del Habla/fisiologíaRESUMEN
Previous studies in our laboratory have demonstrated the preclinical efficacy of nicotinamide (NAM; vitamin B3) treatment following fluid percussion injury (FPI). At a dose of 500 or 50 mg/kg, NAM significantly facilitated recovery of function on a variety of motor and sensorimotor tasks in rodents, and the 500 mg/kg dose improved cognitive performance. The purpose of the present study was to examine the acute neuroprotective ability of NAM following FPI. Rats were given a moderate FPI (1.8 atm) or sham injury. NAM (500 or 50 mg/kg) or saline was administered 15 min and 20 h after FPI. Rats were sacrificed at 24 h or 7 days following injury and prepared for histological analysis. Systematic volumetric measurements were conducted to examine cortical loss in a series of cresyl violet stained slices to examine the development of the injury cavity. To assess the extent of astrocytic activity and neurodegeneration, triple labeling with glial fibrillary acidic protein (GFAP), Fluoro-Jade B (FJ), and DAPI was performed. GFAP(+) astrocytes and FJ(+) neurons in the ipsilateral and contralateral cortex, and ipsilateral hippocampus and thalamus were assessed. While not significant at 24 h, NAM significantly attenuated cortical tissue loss at 7 days. At 24 h, the number of GFAP(+) astrocytes was significantly reduced by NAM. However, the inverse was observed at 7 days where NAM treatment significantly increased the number of GFAP(+) astrocytes. Both doses of NAM also significantly reduced FJ expression at the 24-h and 7-day time intervals. The results of this study suggest that NAM has strong neuroprotective abilities in the injured brain and may have therapeutic potential for brain injury.
Asunto(s)
Química Encefálica/fisiología , Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/metabolismo , Proteína Ácida Fibrilar de la Glía/metabolismo , Fármacos Neuroprotectores , Niacinamida/farmacología , Animales , Astrocitos/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Química Encefálica/efectos de los fármacos , Lesiones Encefálicas/psicología , Recuento de Células , Corteza Cerebral/patología , Fluoresceínas , Técnica del Anticuerpo Fluorescente , Colorantes Fluorescentes , Inmunohistoquímica , Degeneración Nerviosa/patología , Degeneración Nerviosa/prevención & control , Neuronas/patología , Compuestos Orgánicos , Ratas , Ratas Sprague-DawleyRESUMEN
Seizures and subclinical seizures occur following experimental brain injury in rats and may result from inhibitory neuron loss. This study numerically compares cortical and hippocampal glutamic acid decarboxylase (GAD) positive neurons between sham fluid percussion injury (FPI), FPI with sham Vagus Nerve Simulation (VNS), and FPI with chronic intermittent VNS initiated at 24 h post FPI in rats. Rats (n=8/group) were prepared for immunocytochemistry of GAD at 15 days post FPI. Serial sections were collected and GAD immunoreactive neurons were counted in the hippocampal hilus and two levels of the cerebral cortex. Numbers of quantifiable GAD cells in the rostral cerebral cortices were different between groups, both ipsilateral and contralateral to the FPI. Post hoc analysis of cell counts rostral to the ipsilateral epicenter, revealed a significant 26% reduction in the number of GAD cells/unit area of cerebral cortex following FPI. In the FPI-VNS group, this percentage loss was attenuated to only an 8.5% reduction, a value not significantly different from the sham group. In the contralateral side of the rostral cerebral cortex, FPI induced a significant 24% reduction in GAD cells/unit area; whereas, the VNS-treated rats showed no appreciable diminution of GAD cells rostral to the contralateral epicenter. Hippocampal analysis revealed a similar reduction of GAD cells in the FPI group; however, unlike the cortex this was not statistically significant. In the FPI-VNS group, a trend towards increased numbers of hilar GAD cells was observed, even over and above that of the sham FPI group; however, this was also not statistically significant. Together, these data suggest that VNS protects cortical GAD cells from death subsequent to FPI and may increase GAD cell counts in the hippocampal hilus of the injured brain.
Asunto(s)
Lesiones Encefálicas/terapia , Estimulación Eléctrica/métodos , Neuronas/metabolismo , Nervio Vago/efectos de la radiación , Ácido gamma-Aminobutírico/metabolismo , Animales , Lesiones Encefálicas/patología , Recuento de Células/métodos , Modelos Animales de Enfermedad , Glutamato Descarboxilasa/metabolismo , Hipocampo/patología , Inmunohistoquímica , Masculino , Ratas , Ratas Long-Evans , Nervio Vago/fisiopatologíaRESUMEN
This study examined the ability of nicotinamide (vitamin B3) to improve functional outcome in a dose-dependent manner following fluid percussion injury (FPI). Injured (duration of unconsciousness mean = 85.8 sec; apnea = 9.9 sec), rats were administered nicotinamide (500 or 50 mg/kg; ip) or saline at 15 min and 24 h. Serum analysis of nicotinamide concentrations were conducted 1 h following the last injection. Sensorimotor and cognitive tests were conducted for 35 days following FPI. Both the 500 and 50 mg/kg doses of nicotinamide significantly facilitated recovery on the vibrissae-forelimb placing test compared to saline treatment, which showed chronic impairments. Both treatments also significantly improved performance on the bilateral tactile adhesive removal test. On the cognitive tests, the 500 mg/kg dose, but not the 50 mg/kg dose, improved performance on a working memory task in the Morris water maze (MWM). However, acquisition of a reference memory task in the MWM was not improved. Serum analysis showed that the 500 mg/kg dose significantly raised nicotinamide concentrations by 30-fold and the 50 mg/kg dose by 3-fold compared to the saline administration. This study demonstrated that raising nicotinamide concentrations resulted in the reduction of the behavioral impairments following FPI. In fact, the 500 mg/kg dose prevented the occurrence of the behavioral deficits on the bilateral tactile removal and working memory tests. Both doses significantly reduced tissue loss and glial fibrillary acid protein (GFAP) expression in the cortex. The 500 mg/kg dose reduced GFAP expression in the hippocampus. This data suggests that nicotinamide has substantial preclinical efficacy for TBI, and there appears to be some differences in the ability of the doses to improve performance in the MWM.
Asunto(s)
Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/psicología , Trastornos Mentales/etiología , Trastornos Mentales/prevención & control , Niacinamida/administración & dosificación , Complejo Vitamínico B/administración & dosificación , Animales , Lesiones Encefálicas/fisiopatología , Cognición/efectos de los fármacos , Cognición/fisiología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Ratas , Ratas Sprague-Dawley , Tacto/efectos de los fármacos , Tacto/fisiología , Vestíbulo del Laberinto/efectos de los fármacos , Vestíbulo del Laberinto/fisiopatologíaRESUMEN
Recent evidence from our laboratory demonstrated in laboratory rats that stimulation of the vagus nerve (VNS) initiated 2 h after lateral fluid percussion brain injury (FPI) accelerates the rate of recovery on a variety of behavioral and cognitive tests. VNS animals exhibited a level of performance comparable to that of sham-operated uninjured animals by the end of a 2-week testing period. The effectiveness of VNS was further evaluated in the present study in which initiation of stimulation was delayed until 24 h post-injury. Rats were subjected to a moderate FPI and tested on the beam walk, skilled forelimb reaching, locomotor placing, forelimb flexion and Morris water maze tasks for 2 weeks following injury. VNS (30 sec trains of 0.5 mA, 20.0-Hz biphasic pulses) was initiated 24 h post-injury and continued at 30-min intervals for the duration of the study, except for brief periods when the animals were detached for behavioral assessments. Consistent with our previous findings when stimulation was initiated 2 h post-injury, VNS animals showed significantly faster rates of recovery compared to controls. By the last day of testing (day 14 post-injury), the FPI-VNS animals were performing significantly better than the FPI-no-VNS animals and were not significantly different from shams in all motor and sensorimotor tasks. Performance in the Morris water maze indicated that the VNS animals acquired the task more rapidly on days 11-13 post-injury. On day 14, the FPI-VNS animals did not differ in the latency to find the platform from sham controls, whereas the injured controls did; however, the FPI-VNS animals and injured controls were not significantly different. Despite the lack of significant histological differences between the FPI groups, VNS, when initiated 24 h following injury, clearly attenuated the ensuing behavioral deficits and enhanced acquisition of the cognitive task. The results are discussed with respect to the norepinephrine hypothesis.